180 related articles for article (PubMed ID: 19787837)
1. Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review.
Hsieh PM; Hung KC; Chen YS
World J Gastroenterol; 2009 Oct; 15(37):4726-8. PubMed ID: 19787837
[TBL] [Abstract][Full Text] [Related]
2. [Tumor lysis syndrome after transarterial embolization for hepatocellular carcinoma].
Nishida Y; Fujii H; Hagihara A; Kawamura E; Iwai S; Enomoto M; Tamori A; Arakawa T; Kawada N
Nihon Shokakibyo Gakkai Zasshi; 2013 Mar; 110(3):441-8. PubMed ID: 23459539
[TBL] [Abstract][Full Text] [Related]
3. Acute tumor lysis syndrome after transarterial chemoembolization for well-differentiated hepatocellular carcinoma with neuroendocrine features.
Wang K; Chen Z
Onkologie; 2010; 33(10):532-5. PubMed ID: 20926901
[TBL] [Abstract][Full Text] [Related]
4. Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma.
Shiba H; Ishida Y; Wakiyama S; Sakamoto T; Misawa T; Yanaga K
Cancer Sci; 2008 Oct; 99(10):2104-5. PubMed ID: 19016772
[TBL] [Abstract][Full Text] [Related]
5. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma.
Sakamoto N; Monzawa S; Nagano H; Nishizaki H; Arai Y; Sugimura K
Cardiovasc Intervent Radiol; 2007; 30(3):508-11. PubMed ID: 17242878
[TBL] [Abstract][Full Text] [Related]
6. Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma.
Burney IA
South Med J; 1998 May; 91(5):467-70. PubMed ID: 9598857
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma.
Tsai WL; Liang PC; Chen CH
J Formos Med Assoc; 2012 Dec; 111(12):724-5. PubMed ID: 23265753
[No Abstract] [Full Text] [Related]
8. Acute pancreatitis induced by transarterial chemoembolization: a single-center experience of over 1500 cases.
She WH; Chan AC; Cheung TT; Chok KSh; Chan SC; Poon RT; Lo CM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):93-8. PubMed ID: 26818549
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
10. Tumour Lysis Syndrome: a Rare Complication of Trans-Arterial Chemo-Embolisation with Doxorubicin Beads for Hepatocellular Carcinoma.
Katiman D; Manikam J; Goh KL; Abdullah BJ; Mahadeva S
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S187-90. PubMed ID: 22692948
[No Abstract] [Full Text] [Related]
11. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
Lin XJ; Lao XM; Shi M; Li SP
Dig Dis Sci; 2016 Sep; 61(9):2465-76. PubMed ID: 27105647
[TBL] [Abstract][Full Text] [Related]
12. Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient.
Kim JO; Jun DW; Tae HJ; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC; Hahm JS
Clin Mol Hepatol; 2015 Mar; 21(1):85-8. PubMed ID: 25834806
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
14. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Pinter M; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Stauber R; Grünberger B; Müller C; Kölblinger C; Peck-Radosavljevic M; Sieghart W
Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359
[TBL] [Abstract][Full Text] [Related]
15. Tumor Lysis Syndrome: A Serious Complication of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Jiang RD; Jian WC; Jin N; Zhang ZL; Li T
Am J Med; 2016 Sep; 129(9):e173-6. PubMed ID: 27155110
[No Abstract] [Full Text] [Related]
16. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
[TBL] [Abstract][Full Text] [Related]
17. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M
Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
[TBL] [Abstract][Full Text] [Related]
19. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres
Sun J; Zhou G; Xie X; Gu W; Huang J; Zhu D; Hu W; Hou Q; Shi C; Li T; Zhang X; Ji W; Ying S; Peng Z; Zhou J; Yu Z; Ji J; Du H; Guo X; Fang J; Han J; Xu H; Sun Z; Yu W; Shao G; Wu X; Hu H; Li L; Zheng J; Luo J; Chen Y; Cao G; Hu T
Oncol Res; 2020 Feb; 28(1):75-94. PubMed ID: 31558180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
